Literature DB >> 2818445

Atrial bioenergetic variations in moderate hypoxia: danger or protective defense?

L Caparrotta1, R Poja, E Ragazzi, G Froldi, L Pandolfo, M Prosdocimi, G Fassina.   

Abstract

The effects of hypoxia on contractile tension and on tissue adenylate pool content, nicotinamide adenine nucleotide, NAD, nicotinamide adenine dinucleotide phosphate, NADP, and creatine phosphate, CrP, were investigated in isolated, spontaneously beating, guinea pig atria. When two different degrees of hypoxia were induced by lowering oxygen tension from 95% O2 (control) to 40% (moderate hypoxia) and 20% (severe hypoxia) for 30 min, contractile tension slowly decreased to 60% and 40% of control, respectively. In 40% O2 hypoxic atria, ATP was not significantly decreased, AMP slightly increased, TAN (total adenylate nucleotides) and adenylate energy charge [(ATP + 0.5 ADP)/(ATP + ADP + AMP)] did not change and creatine phosphate was decreased down to 53%. Hypoxic atria in 20% O2 showed a significant decrease of 26% in ATP, while ADP and AMP increased four and seven times, respectively. The adenylate energy-charge value was reduced from 0.93 to 0.70. Creatine phosphate decreased to below the analytical detection limit. Moderate hypoxia (40% O2), which induced a significant decrease of contractile tension but only minor changes of energetic tissue metabolism, was further investigated 2, 5, and 10 min after low oxygen tension was applied. Two stages of variations were evident during 30 min of experimental hypoxia. Within the first 10 min, concomitantly with atrial tension decrease, ATP, NAD, NADP, ATP/AMP, ATP/ADP, and TAN decreased, CrP began to decrease, inosine and xanthine showed no significant change. During the following 20 min of hypoxia, all parameters returned to the control levels with the exception of creatine phosphate. Adenylate energy charge did not change. The electrophysiological analysis of atrial cells did not show any major change in action potential configuration and resting potential, during 40% O2 hypoxia. The differences at metabolic level between moderate and more severe hypoxia suggest that the energetic state may be extremely unbalanced, in atrial tissue, as long as hypoxia is aggravated. Moreover, the time-course study, during 30 min of 40% O2, suggests that the early decrease of contractile tension does not depend on lowered energy availability, instead it might be, at least in part, a preventive measure to maintain energy balance in myocardial tissue to counteract hypoxic damage and, in this mechanism of defense, creatine phosphate shuttle seems to play a relevant role.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818445     DOI: 10.1007/BF01908197

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  31 in total

Review 1.  Myocardial ischemia (first of three parts).

Authors:  L D Hillis; E Braunwald
Journal:  N Engl J Med       Date:  1977-04-28       Impact factor: 91.245

2.  Mechanism of early "pump" failure of the ischemic heart: possible role of adenosine triphosphate depletion and inorganic phosphate accumulation.

Authors:  W Kübler; A M Katz
Journal:  Am J Cardiol       Date:  1977-09       Impact factor: 2.778

3.  Functional compartmentation of ATP and creatine phosphate in heart muscle.

Authors:  S Gudbjarnason; P Mathes; K G Ravens
Journal:  J Mol Cell Cardiol       Date:  1970-09       Impact factor: 5.000

4.  The oxygen paradox and the calcium paradox: two facets of the same problem?

Authors:  D J Hearse; S M Humphrey; G R Bullock
Journal:  J Mol Cell Cardiol       Date:  1978-07       Impact factor: 5.000

5.  Total ischemia in dog hearts, in vitro 2. High energy phosphate depletion and associated defects in energy metabolism, cell volume regulation, and sarcolemmal integrity.

Authors:  K A Reimer; R B Jennings; M L Hill
Journal:  Circ Res       Date:  1981-10       Impact factor: 17.367

6.  Lanthanum probe studies of cellular pathophysiology induced by hypoxia in isolated cardiac muscle.

Authors:  K P Burton; H K Hagler; G H Templeton; J T Willerson; L M Buja
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

7.  Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias.

Authors:  J R Parratt; S J Coker
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

8.  Compartmentation of cardiac adenine nucleotides and formation of adenosine.

Authors:  J Schrader; E Gerlach
Journal:  Pflugers Arch       Date:  1976-12-28       Impact factor: 3.657

9.  Release of two vasodilators, adenosine and prostacyclin, from isolated rabbit hearts during controlled hypoxia.

Authors:  A Edlund; B B Fredholm; P Patrignani; C Patrono; A Wennmalm; M Wennmalm
Journal:  J Physiol       Date:  1983-07       Impact factor: 5.182

10.  Two levels of resting potential in cardiac Purkinje fibers.

Authors:  D C Gadsby; P F Cranefield
Journal:  J Gen Physiol       Date:  1977-12       Impact factor: 4.086

View more
  3 in total

Review 1.  Structural Analysis of Mitochondrial Dynamics-From Cardiomyocytes to Osteoblasts: A Critical Review.

Authors:  Daniel H Mendelsohn; Katja Schnabel; Andreas Mamilos; Samuel Sossalla; Steffen Pabel; Georg Daniel Duerr; Karsten Keller; Volker H Schmitt; Friedrich Barsch; Nike Walter; Ronald Man Yeung Wong; Thaqif El Khassawna; Tanja Niedermair; Volker Alt; Markus Rupp; Christoph Brochhausen
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Phentolamine and hypoxia: modulation of contractility and alpha 1-adrenoceptors in isolated rat atria.

Authors:  G Froldi; L Guerra; L Pandolfo; A Chinellato; E Ragazzi; L Caparrotta; P A Borea; G Fassina
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

3.  Does Levetiracetam Administration Prevent Cardiac Damage in Adulthood Rats Following Neonatal Hypoxia/Ischemia-Induced Brain Injury?

Authors:  Serkan Gurgul; Belgin Buyukakilli; Mustafa Komur; Cetin Okuyaz; Ebru Balli; Tuba Ozcan
Journal:  Medicina (Kaunas)       Date:  2018-04-10       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.